These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9738856)
1. Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. Goldstein BP; Wei J; Greenberg K; Novick R J Antimicrob Chemother; 1998 Aug; 42(2):277-8. PubMed ID: 9738856 [No Abstract] [Full Text] [Related]
2. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria. Lu J; Yoshida O; Hayashi S; Arimoto H Chem Commun (Camb); 2007 Jan; (3):251-3. PubMed ID: 17299629 [TBL] [Abstract][Full Text] [Related]
3. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae. Knudsen JD Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae. Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of pneumococcal bacteremia, in vitro resistance, and antibiotic therapy. Torres-Tortosa M; Caballero-Granado J; Canueto J; Moreno-Maqueda I Clin Infect Dis; 2004 Mar; 38(5):763-4; author reply 765-6. PubMed ID: 14986265 [No Abstract] [Full Text] [Related]
6. Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002). Jones RN; Sader HS; Fritsche TR Diagn Microbiol Infect Dis; 2004 Jun; 49(2):147-9. PubMed ID: 15183865 [TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of nisin against clinical isolates of Clostridium difficile. Bartoloni A; Mantella A; Goldstein BP; Dei R; Benedetti M; Sbaragli S; Paradisi F J Chemother; 2004 Apr; 16(2):119-21. PubMed ID: 15216943 [TBL] [Abstract][Full Text] [Related]
13. Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor. Gross M; Clements J; Beckett RP; Thomas W; Taylor S; Lofland D; Ramanathan-Girish S; Garcia M; Difuntorum S; Hoch U; Chen H; Johnson KW J Antimicrob Chemother; 2004 Mar; 53(3):487-93. PubMed ID: 14963065 [TBL] [Abstract][Full Text] [Related]
14. Specific antibodies, levofloxacin, and modulation of capsule-associated virulence in Streptococcus pneumoniae. Tarragó D; Lara N; Fenoll A; Casal J; Giménez MJ; Aguilar L; Sevillano D Antimicrob Agents Chemother; 2005 Jul; 49(7):3095-6. PubMed ID: 15980409 [No Abstract] [Full Text] [Related]
15. Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review. Siegel M; Timpone J Clin Infect Dis; 2001 Mar; 32(6):972-4. PubMed ID: 11247720 [TBL] [Abstract][Full Text] [Related]
16. Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones. Huelves L; Sevillano D; Martínez-Marín C; López-Casla MT; Gracia M; Alou L; del Carmen Ponte M; Prieto J; Soriano F; Int J Antimicrob Agents; 2006 Apr; 27(4):294-9. PubMed ID: 16527462 [TBL] [Abstract][Full Text] [Related]
17. The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci. Arnusch CJ; Bonvin AM; Verel AM; Jansen WT; Liskamp RM; de Kruijff B; Pieters RJ; Breukink E Biochemistry; 2008 Dec; 47(48):12661-3. PubMed ID: 18989934 [TBL] [Abstract][Full Text] [Related]
18. A real-time polymerase chain reaction for the detection of Streptococcus pneumoniae in blood using a mouse model: a potential new "gold standard". Rouphael NG; Atwell-Melnick N; Longo D; Whaley M; Carlone GM; Sampson JS; Ades EW Diagn Microbiol Infect Dis; 2008 Sep; 62(1):23-5. PubMed ID: 18621498 [TBL] [Abstract][Full Text] [Related]
19. Changing trends in antimicrobial-resistant pneumococci: it's not all bad news. Low DE Clin Infect Dis; 2005 Aug; 41 Suppl 4():S228-33. PubMed ID: 16032557 [TBL] [Abstract][Full Text] [Related]
20. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model. Suntur BM; Yurtseven T; Sipahi OR; Buke C; Buke M Int J Antimicrob Agents; 2005 Sep; 26(3):258-60. PubMed ID: 16099624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]